Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT Study

NCT05224271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2024-09-19

No results posted yet for this study

Summary

This study explores the use of the Hugo platform to involve study participants in their healthcare and treatments. The Hugo platform may allow researchers to collect better and more accurate real-time health data, from other clinics/hospitals, pharmacies and other electronic devices. The purpose of this research is to see if the use of the Hugo platform is consistent, accurate, cost effective, and time efficient, as it collects and transmits important real-time health information from other clinics/hospitals, pharmacies, and other electronic devices.

Conditions

  • Breast Carcinoma
  • Head and Neck Carcinoma
  • Lung Carcinoma
  • Malignant Solid Neoplasm

Interventions

OTHER

Electronic Health Record Review

Medical records are collected

OTHER

Medical Device Usage and Evaluation

Fitbit information is collected

OTHER

Survey Administration

Complete surveys

Sponsors & Collaborators

Principal Investigators

  • Kimberly S. Corbin, MD · Mayo Clinic in Rochester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-02
Primary Completion
2023-04-10
Completion
2023-04-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05224271 on ClinicalTrials.gov